InfoTechTarget and Informa Tech's Digital Businesses Combine.

Together, we power an unparalleled network of 220+ online properties covering 10,000+ granular topics, serving an audience of 50+ million professionals with original, objective content from trusted sources. We help you gain critical insights and make more informed decisions across your business priorities.

The benefits of generative AI in every stage of drug discovery

Presented by

Marissa Powers, PhD, Solutions Architect, HPC Life Sciences, AWS | David Ruau, PhD, EMEA Business Development Lead, Healthcare and Life Sciences, NVIDIA | Megan Thomas, Multimedia Editor, Drug Discovery World

About this talk

It can take years, and cost billions, to get new drugs approved for clinical use but technological advances are transforming drug discovery and development. The growing shift towards artificial intelligence (AI), including generative and predictive AI, can reduce the amount of time and money it takes to develop new drugs. It offers the potential to drastically shorten the early stages of drug discovery and help identify future drug candidates faster. Hear from AWS and NVIDIA experts and discover how high performance computing (HPC) and AI are being used to screen out potentially dangerous drugs, improve identification of drug candidates, and develop new therapeutic compounds. Learn how: • To overcome common challenges from data quality, managing multi-modal data, and limited computational resources • Generative AI is impacting and accelerating the drug discovery process • Accelerated compute and purpose-built tools can help build, run, and train generative AI workloads
Generative AI with AWS and NVIDIA

Generative AI with AWS and NVIDIA

2042 subscribers12 talks
Empowering developers with cutting-edge tools for AI innovation
Amazon Web Services (AWS) and NVIDIA have collaborated since 2010 to continually deliver large-scale, cost-effective, and flexible GPU-accelerated services for customers. Explore the interview and webinar resources in this channel to discover how their collaboration empowers millions of developers to access cutting-edge technologies essential for driving rapid innovation in generative AI.
Related topics